BioMed21 Collaboration retweeted
ICYMI: Our new “moonshot” policy paper with @BioMed_21 calls for a bold shift from outdated animal tests to human-relevant, animal-free methods that better predict how diseases & treatments affect people.
Read more in our latest @POLITICOEurope article: politico.eu/sponsored-conten…
BioMed21 Collaboration retweeted
We welcome the publication of UK Government's plan for replacing animal in science. Animal-free methods provide better safety for humans, environment & prevent animal suffering. We look forward to contributing our experience & expertise to ensure implementation of this strategy.
BioMed21 Collaboration retweeted
👀 We’re back with tips for researchers to mitigate animal methods bias in grant peer review!
Panelists at our workshop highlighted the hesitancy of certain reviewers to embrace animal-free technology, despite growing evidence of the poor clinical translation of animal studies.
BioMed21 Collaboration retweeted
On March 26, COLAAB member Dr. Owen Kavanagh will be providing an update on our award-winning work on #AnimalMethodsBias at the Best Practice in Non-Animal Research Conference in York, UK!
More info about the conference here: replacinganimalresearch.org.….
BioMed21 Collaboration retweeted
📢 Deadline EXTENDED!
Last chance to register for the Microphysiological Systems Bootcamp! Now 𝙁𝙚𝙗𝙧𝙪𝙖𝙧𝙮 6𝙩𝙝, 2025!
Hands-on with 3D Bioprinting, Organoids, Microfluidics & more at @NIPERAHM.
Register now: lnkd.in/g8eNkjrE
BioMed21 Collaboration retweeted
📝 New blog alert! We've recapped 10 of the most impactful Organ-Chip publications from 2024. From uncovering new disease mechanisms to advancing drug safety and efficacy testing, read on to learn how Organ-Chips are being used to advance human health!
hubs.ly/Q032VY_90
BioMed21 Collaboration retweeted
CPHMS 𝗠𝗶𝗰𝗿𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗕𝗼𝗼𝘁𝗰𝗮𝗺𝗽 Edition #3 is here and registrations open today!
Join us for an immersive experience with leading experts from @NIPERAHM, @iitgn!
Discover the speaker lineup.
L𝗶𝗻𝗸: lnkd.in/g8eNkjrE
BioMed21 Collaboration retweeted
Beyond bringing us closer to personalised medicine & animal-free testing, organ-on-chip technology could also enhance the EU's competitiveness.
Currently, this technology is not fully integrated into clinical practice.
JRC scientists are here to help: europa.eu/!kbBf8V
BioMed21 Collaboration retweeted
🚨 Attention #Editors & #Publishers 🚨
The COLAAB is looking for your input on ways to improve fairness in the review of biomedical research studies—specifically related to an emerging #peerreview bias called #animalmethodsbias.👇
Survey here: bit.ly/3Zw63l0

ALT Editors & Publishers: We’re investigating ways to improve fairness in reviewing nonanimal biomedical research methods and are looking for your input. What interventions to mitigate bias have proven effective at your journal(s), and what might you be open to trying to counteract animal methods bias?

ALT Animal Methods Bias: The preference for animal-based research methods or the lack of expertise to adequately evaluate nonanimal methods, such as complex in vitro models. Animal methods bias can cause reviewers to expect or request animal experiments, which authors often feel are not scientifically justified.
BioMed21 Collaboration retweeted
Join our quick 5-minute survey with @IndiaHSI & @IndiaBioscience to discuss the challenges of justifying in vitro findings with animal experiments during peer review.
Link: lnkd.in/gpebfX-S
BioMed21 Collaboration retweeted
Greetings!
@IndiaHSI/India, @IndiaBioscience and we are surveying to assess peer-review experiences in India while submitting in vitro data to a journal. Let us know your thoughts by participating in this survey. Link: pcrm.sjc1.qualtrics.com/jfe/…
BioMed21 Collaboration retweeted
Catharine E. Krebs of the COLAAB and @PCRM presented a poster on #AnimalMethodsBias at #ASCCT this week! She discussed what we know about this phenomenon, its damaging effects on researchers who use #NAMs, what remains TBD, and our recommendations for overcoming it.
BioMed21 Collaboration retweeted
Are you a researcher working on in vitro models like organoids, organ-on-chip, or iPSCs?
Join our 5-minute survey with @IndiaBioscience and @cphms_aic , to share your views on in vitro data submissions.
Scan the QR code now!
BioMed21 Collaboration retweeted
Francesca Pistollato, a Biomedical Research Senior Strategist at @HSIGlobal & COLAAB member, recently attended @EUROoCS to present a poster on #AMB: the preference for animal methods or lack of expertise to properly evaluate #nonanimal methods, resulting in unfair assessments.
BioMed21 Collaboration retweeted
The COLAAB website is live!
👉animalmethodsbias.org
It provides info about #AnimalMethodsBias and houses the resource we created for researchers who use animal-free approaches to help avoid its negative consequences. Check it out and share with your colleagues!
BioMed21 Collaboration retweeted
Join us at our upcoming MPS Bootcamp in Bangalore! We are excited to unveil the comprehensive workshop schedule, featuring engaging hands-on sessions and expert talks.
BioMed21 Collaboration retweeted
Wyss Institute researchers have developed a human Cervix-on-a-Chip that overcomes major limitations of other models and enables the study of bacterial vaginosis. #WomensHealth #OrganChips @DonIngber
wyss.harvard.edu/news/human-…
BioMed21 Collaboration retweeted
The website for #WC13 is live! Please make note of the following deadlines:
📌September 30, 2024: Session proposals due
📌February 24, 2025: Abstracts due
📌March 1, 2025: Registration opens
We hope to see you all in Rio! 🇧🇷
wc13rio.org/
BioMed21 Collaboration retweeted
.@TheCOLAAB are running a free online workshop to explore animal methods bias in biomedical research funding May 16th - we hope to see you there!
eventbrite.co.uk/e/workshop-…
BioMed21 Collaboration retweeted
Hear from our colleague @PSurat22 about the exciting move towards human-based tech in drug development! Join our webinar on "Taking the leap towards Microphysiological Systems (MPS): Role of standards and funding"!
events.teams.microsoft.com/e…



























